Tissue Culture Propagation Firm Front Range Biosciences Raises $1,500,000

LAFAYETTE, Colorado – February 21, 2017 – Front Range Biosciences (FRB), the agricultural biotechnology company for high value crops, announced today that it raised $1.5 million in funding.

Salveo Capital Executes First Closing, Completes Initial Investments

Salveo Capital is a private equity fund dedicated to supporting high growth businesses supporting the legal cannabis ecosystem, with a focus on companies across a few sectors: information, data & analytics; financial payments & services; medical products, formulations & delivery; ag-tech & grow systems; and business services.

Salveo has completed investments in Headset and Front Range Biosciences. Headset is a Washington state located firm providing key actionable analytics to manufacturers and retailers within the cannabis industry. Front Range is a biotechnology providing a cost effective method to produce disease-free clones.

Cannabis Analytics Company Headset Raises $2.5MM

SEATTLE, Jan. 19, 2017 /PRNewswire/ -- Headset, Inc., a leading retail analytics firm for cannabis-related businesses, announced today it has closed $2.5 million in financing as it ramps up its sophisticated suite of data products.

Hypur Ventures, a leading-edge venture capital fund headquartered in Arizona, and Salveo Capital, a Chicago-based private-equity fund specializing in cannabis sector investments, have partnered with Headset to provide a deeper, richer set of tools for the emerging market.

"With this most recent fundraising, we are excited to be able to accelerate development andadoption of Headset products across all legal cannabis markets," said Cy Scott, co-founder and CEO. "Headset is well positioned to help the cannabis industry make more informed business decisions supported by retail transaction data."

Some Alternative Funders See Pot As Next Big Market Opportunity

For some funders, marijuana is not just about sewing their wild oats. Rather, they see the business potential of being early to what’s expected to be a highly profitable and long-lasting party.

Salveo Capital Joins 16-Strong Cannabis Fund Market With Upgraded Team

“A lot of new initiatives are coming on. Before, we didn’t have states that were adding laws and awarding licenses, so there was a bit of a lag in the market that has started to change in about the last year,” explained Thiersch. “Now it is humming on all cylinders and we are seeing a ton of movement. There will be a lot of opportunity in the next one to two years especially if some of the big East Coast cities that are huge markets open up."

Salveo Capital Re-launches Cannabis-Focused Salveo Fund I

The fund’s primary investment space will be in early stage ancillary businesses that enable the legal cannabis industry and that are not subject to state regulations. Key investment areas will include financial, payment, and banking businesses, grow systems, agriculture and operations, software, digital and IOT, genetics, chemistry, and business services.

How Big Is The Market For Legal Pot!

Ready or not, with its legalization in several states and those old-school taboos surrounding weed being febrezed away, a massive dollar sign hangs above Marijuana industry as its potential growth projections outpace the smartphone industry.

Institutional Investment Into Cannabis Is Inevitable

Up to this point financing of legal cannabis in the U.S. has relied largely on private money - friends and family raises, high net-worth individuals, and small to medium sized private investment firms. Banks and large investors have shied away from companies in the cannabis space, even for businesses that do not touch the plant. The federal prohibition on cannabis has led to this situation in which small investors and venture funds have become the industry’s financial backbone. This moment in time of individual investing power in cannabis is waning, however. As cannabis normalizes and as laws relax industry participation by institutional investors is inevitable. The only question is how prepared current cannabis stakeholders will be when it happens.

Professional Athletes Call for Action on Medical Cannabis

Across multiple sports athletes have stated that cannabis could be a superior treatment for sports-related injuries, without the drawbacks of current opioid pain medications.

The Most Effective Cannabis Legalization Strategy Is to Put Patients First

Yes, full personal use legalization would by definition give access to the widest range of patients, but it’s a reality that a large chunk of voters and legislators do not support fully legal cannabis. Step by step legalization, prioritizing medical access, has worked across the country at alleviating the suffering of countless people while also providing much needed education for skeptics. It’s important to push for what can pass, and then work from within that system to make people comfortable with more.

Will 2016 Be the Year of Cannabis?

Of course the big news federally is this year's Presidential election, and virtually every serious candidate now at the very least supports the continuation of allowing states to make their own cannabis laws. This, of course, reflects the huge popularity of medical cannabis among the population at large and in swing states in particular.

With so much opportunity on the horizon, while 2014 will probably always be remembered as the tipping point, 2016 might truly be The Year of Cannabis.

This Investor Wants to Fund the J. Crew of Pot Dispensaries

As more and more states move toward legalizing marijuana, investors are exploring how to capitalize on the increasing growth of the industry. But there's still one thing giving some capitalists pause: branding.

Alex Theirsch, managing principal for Salveo Captial, a private equity firm investing in legal weed, told HuffPost Live on Thursday that the stigma of marijuana is a turn-off for potential customers who don't fit the typical stoner stereotype.